CanMED: NDC
Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 April 30, 2014 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 Nov. 30, 2013 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 June 30, 2014 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 March 31, 2011 No Longer Used. ...
CanMED: NDC
cytarabine. Cytarabine. 2.0 g/20mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. July ...
CanMED: NDC
Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 April 30, 2014 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 Nov. 30, 2013 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 June 30, 2014 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 March 31, 2011 No Longer Used. ...
CanMED: NDC
Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 April 30, 2014 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 Nov. 30, 2013 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 June 30, 2014 No Longer Used. ... Cytarabine. Cytarabine. Chemotherapy Antimetabolite Pyrimidine Analog. May 1, 1996 March 31, 2011 No Longer Used. ...
CanMED: NDC
Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intravenous, Subcutaneous. Dec. 14, 2011 Dec ... Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intravenous, Subcutaneous. June 30, 2014 ... Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intravenous, Subcutaneous. Dec. 14, 2011 ... Cytarabine. Cytarabine. 2.0 g/20mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. Jan ...
CanMED: NDC
Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intravenous. Aug. 31, 1990 In Use. ... Cytarabine. DepoCyt. 50.0 mg/5mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal. Oct. 22, 2010 June 30, 2018 No ...
CanMED: HCPCS
Cytarabine Cytarabine. 100 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 2004 Dec. 31, 2005 No Longer ... Cytarabine Cytarabine. 500 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 1994 Dec. 31, 2010 No Longer ... Cytarabine Cytarabine Liposome. 10 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1999. Jan. 1, 2004 In Use. ... Cytarabine Cytarabine. 100 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 1986 In Use. ...
CanMED: HCPCS
Cytarabine Cytarabine. 100 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 2004 Dec. 31, 2005 No Longer ... Cytarabine Cytarabine. 500 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 1994 Dec. 31, 2010 No Longer ... Cytarabine Cytarabine Liposome. 10 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1999. Jan. 1, 2004 In Use. ... Cytarabine Cytarabine. 100 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 1986 In Use. ...
CanMED: NDC
Cytarabine. Cytarabine. 100.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. Dec ... Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. Dec ...
CanMED: NDC
Cytarabine. Cytarabine. 2.0 g/20mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. Jan ...
CanMED: NDC
Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intravenous, Subcutaneous. Feb. 28, 2022 In ...
CanMED: NDC
cytarabine. Cytarabine. 2.0 g/20mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. July ... Cytarabine. Cytarabine. 100.0 mg/5mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. ... Cytarabine. Cytarabine. 100.0 mg/5mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intrathecal, Intravenous, Subcutaneous. ...
CanMED: HCPCS
Cytarabine Cytarabine Liposome. 10 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1999. Jan. 1, 2004 In Use. ... Cytarabine Cytarabine. 100 mg. Chemotherapy Antimetabolite. Pyrimidine Analog. No 1998. Jan. 1, 1986 In Use. ...
00069-0154 Cytarabine - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
CanMED: NDC
Cytarabine. Cytarabine. 20.0 mg/mL. Chemotherapy Antimetabolite Pyrimidine Analog. Intravenous, Subcutaneous. Dec. 14, 2011 Dec ...
CanMED: HCPCS
Daunorubicin AND Cytarabine) Liposome Vyxeos. 1mg/2.27mg. Chemotherapy Antitumor Antibiotic & Antimetabolite. Anthracycline & ...
CanMED: HCPCS
Daunorubicin AND Cytarabine) Liposome Vyxeos. 1mg/2.27mg. Chemotherapy Antitumor Antibiotic & Antimetabolite. Anthracycline & ...
Yves Pommier, M.D., Ph.D. | Center for Cancer Research
... cytarabine, gemcitabine, methotrexate) are widely used and efficient anticancer drugs, biomarkers are lacking to predict the ...
Cytarabine - NCI
This page contains brief information about cytarabine and a collection of links to more information about the use of this drug ... Cytarabine is also approved to prevent and treat:. *Meningeal leukemia (leukemia that has spread to the meninges). It is given ... More About Cytarabine. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. ... Cytarabine is also available in a different form, combined with Daunorubicin Hydrochloride. For more information see the Drug ...
Discovery & Development Services | Developmental Therapeutics Program (DTP)
Cytarabine (ARA-C) (NSC 63878). Procarbazine (NSC 77213). 1995. All-t-retinoic acid (NSC 122758) 1967. Hydroxyurea (NSC 32065) ...